Form4insider filings, from the source

SEC Form 4 · accession 0001225208-19-003741

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Maulik Nanavaty
Officer — SVP & Pres, Neuromodulation
Period of report
Feb 22, 2019
Accepted (ET)
Feb 26, 2019 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 22, 2019M1,883$0.00A254,006D
Common StockF2Feb 22, 2019F934$40.52D253,072D
Common StockF1,F2Feb 23, 2019M1,839$0.00A254,911D
Common StockF2Feb 23, 2019F912$40.52D253,999D
Common StockF1,F2Feb 24, 2019M2,676$0.00A256,675D
Common StockF2Feb 24, 2019F1,327$40.52D255,348D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF1,F3—Feb 22, 2019M1,883D—Feb 22, 2021Common Stock1,8833,766D
Deferred Stock UnitsF1,F4—Feb 23, 2019M1,839D—Feb 23, 2020Common Stock1,8391,840D
Deferred Stock UnitsF1,F5—Feb 24, 2019M2,676D—Feb 24, 2019Common Stock2,6760D

Explanation of responses